XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.9030
-0.0470 (-4.95%)
Apr 1, 2025, 4:00 PM EDT - Market closed
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,104,449
Market Cap
3.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Jan 1, 2022 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XRTX News
- 2 months ago - XORTX Announces Change of Auditor - GlobeNewsWire
- 3 months ago - XORTX Announces Presentation at the Rare and Genetic Disease Summit - GlobeNewsWire
- 5 months ago - XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 6 months ago - XORTX Initiates Precision Medicine Program - GlobeNewsWire
- 7 months ago - XORTX Announces Results of Annual and Special Meeting of Shareholders - GlobeNewsWire
- 7 months ago - XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A - GlobeNewsWire
- 7 months ago - XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders - GlobeNewsWire
- 7 months ago - Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders - GlobeNewsWire